pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
GILEAD · news · pharmadog
← back to GILEAD
News mentioning GILEAD
74
stories
19d
STAT+: Glenmark to pay $29.6 million to settle price-fixing allegations in long-running battle with states
stat
19d
STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more
stat
20d
STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access
stat
20d
STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last year
stat
20d
STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and more
stat
21d
STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
stat
28d
Novartis to acquire ADC developer in a deal worth up to $1.5B
biopharma dive
28d
The race for an Ebola therapy begins
stat
Jun 18, 26
Biogen adds more immune drugs in $1B buyout of secretive startup RayThera
biopharma dive
Jun 11, 26
STAT+: A suspicious denial pattern in Medicare Advantage
stat
Jun 11, 26
STAT+: Novartis doubles down on molecular glue strategy
stat
Jun 11, 26
STAT+: Enliven Therapeutics’ leukemia drug shows promise in new study
stat
Jun 11, 26
STAT+: Private Medicare plans erect barriers to rehab care in pursuit of profit, federal investigators find
stat
Jun 10, 26
STAT+: Hope for Kendall Square’s lab market
stat
Jun 9, 26
STAT+: Trump’s health care affordability czar takes aim at hospitals
stat
Jun 9, 26
Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts
stat
Jun 9, 26
FDA OKs first new sunscreen ingredient in more than 25 years
stat
Jun 9, 26
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
biopharma dive
Jun 9, 26
Gilead and Merck’s latest trial success and flop
stat
Jun 9, 26
Trodelvy misses in lung cancer, but Gilead and Merck have an HIV success
endpoints
Jun 9, 26
STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
stat
May 29, 26
At ASCO, Merck makes case for a ‘cornerstone’ cancer drug
biopharma dive
May 29, 26
Allogene CEO to step down; Agios drug fails key test
biopharma dive
May 29, 26
STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
stat
May 29, 26
Which vaccines will curb the Ebola outbreak? WHO debates
stat
May 28, 26
GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’
biopharma dive
May 22, 26
FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
fda press
May 18, 26
Merck ADC, licensed from China, hits mark in first big global trial
biopharma dive
May 8, 26
Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Cancer
onclive
May 8, 26
Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Cancer
onclive
← prev
page 2 of 3
next →
